يعرض 1 - 17 نتائج من 17 نتيجة بحث عن '"E. I. Pervakova"', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 16, № 4 (2024); 491-499 ; Трансплантология; Том 16, № 4 (2024); 491-499 ; 2542-0909 ; 2074-0506

    وصف الملف: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/942/909; Хубутия М.Ш., Чучалин А.Г., Абакумов М.М., Авдеев С.Н., Тимербаев В.Х., Поплавский И.В., и др. Первая трансплантация легких в НИИ скорой помощи им. Н.В. Склифосовского. Трансплантология. 2011;(2–3):5–9. https://doi.org/10.23873/2074-0506-2011-0-2-3-5-9; Chambers DC, Perch M, Zucker mann A, Cherikh WS, Harhay MO, Hayes D Jr, et al. International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report – 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40(10):1060–1072. PMID: 34446355 https://doi.org/10.1016/j.healun.2021.07.021; Biswas Roy S, Panchanathan R, Walia R, Varsch KE, Kang P, Huang J, et al. Lung retransplantation for chronic rejection: a single-center experience. Ann Thorac Surg. 2018;105(1):221–227. PMID: 29100649 https://doi.org/10.1016/j.athoracsur.2017.07.025; Kawut SM. Lung retransplanta tion. Clin Chest Med. 2011;32(2):367– 377. PMID: 21511096 https://doi.org/10.1016/j.ccm.2011.02.013; Crotti S, Iotti GA, Lissoni A, Belliato M, Zanierato M, Chierichetti M, et al. Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes. Chest. 2013;144(3):1018–1025. PMID: 23599162 https://doi.org/10.1378/chest.12-1141; Inci I, Ehrsam JP, Van Raemdonck D, Ceulemans LJ, Krüger T, Koutsokera A, et al. Extracorporeal life support as a bridge to pulmonary retransplantation: prognostic factors for survival in a multicentre cohort analysis. Eur J Cardiothorac Surg. 2022;61(2):405–412. PMID: 34935039 https://doi.org/10.1093/ejcts/ezab514; Collaud S, Benden C, Ganter C, Hillin ger S, Opitz I, Schneiter D, et al. Extracorporeal life support as bridge to lung retransplantation: a multicenter pooled data analysis. Ann Thorac Surg. 2016;102(5):1680–1686. PMID: 27424471 https://doi.org/10.1016/j.athoracsur.2016.05.014; Grimm JC, Valero V 3rd, Kilic A, Magruder JT, Merlo CA, Shah PD, et al. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. JAMA Surg. 2015;150(6):547–553. PMID: 25874575 https://doi.org/10.1001/jamasurg.2015.12; https://www.jtransplantologiya.ru/jour/article/view/942

  14. 14
    Academic Journal

    المصدر: PULMONOLOGIYA; Том 32, № 6 (2022); 899-905 ; Пульмонология; Том 32, № 6 (2022); 899-905 ; 2541-9617 ; 0869-0189

    وصف الملف: application/pdf

    Relation: https://journal.pulmonology.ru/pulm/article/view/4090/3474; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4090/1422; Sandhaus R.A., Turino G., Brantly M.L. et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr. Pulm. Dis. 2016; 3 (3): 668-682. DOI:10.15326/jcopdf.3.3.2015.0182.; Weill D., Benden C., Corris P.A. et al. A consensus document for the selection of lung transplant candidates: 2014 - an update from the pulmonary transplantation council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2015; 34 (1): 1-15. DOI:10.1016/j.healun.2014.06.014.; Stoller J.K., Aboussouan L.S. Alpha1-antitrypsin deficiency. 5: intravenous augmentation therapy: current understanding. Thorax. 2004; 59 (8): 708-712. DOI:10.1136/thx.2003.006544.; Sandhaus R.A. Alpha1-antitrypsin deficiency. 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax. 2004; 59 (10): 904-909. DOI:10.1136/thx.2003.006551.; Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2021 Report. Available at: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf [Accessed: October 09, 2021].; Anglès R., Tenorio L., Roman A. et al. Lung transplantation for emphysema. Lung hyperinflation: incidence and outcome. Transpl. Int. 2005; 17 (12): 810-814. DOI:10.1007/s00147-004-0714-7.; Faccioli E., Terzi S., Pangoni A. et al. Extracorporeal membrane oxygenation in lung transplantation: Indications, techniques and results. World J. Transplant. 2021; 11 (7): 290-302. DOI:10.5500/wjt.v11.i7.290.; Yusen R.D., Edwards L.B., Dipchand A.I. et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult lung and heart-lung transplant report-2016; Focus theme: Primary diagnostic indications for transplant. J. Heart Lung Transplant. 2016; 35 (10): 1170-1184. DOI:10.1016/j.healun.2016.09.001.; Tanash H.A., Riise G.C., Ekström M.P. et al. Survival benefit of lung transplantation for chronic obstructive pulmonary disease in Sweden. Ann. Thorac. Surg. 2014; 98 (6): 1930-1935. DOI:10.1016/j.athoracsur.2014.07.030.; Chapman K.R., Stockley R.A., Dawkins C. et al. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD. 2009; 6 (3): 177-184. DOI:10.1080/15412550902905961.; Gøtzsche P.C., Johansen H.K. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst. Rev. 2010; (7): CD007851. DOI:10.1002/14651858.cd007851.pub2.; McElvaney N.G., Burdon J., Holmes M. et al. Long-term efficacy and safety of а1 proteinase inhibitor treatment for emphysema caused by severe а1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). Lancet Respir. Med. 2017; 5 (1): 51-60. DOI:10.1016/S2213-2600(16)30430-1.; https://journal.pulmonology.ru/pulm/article/view/4090

  15. 15
    Academic Journal

    المصدر: PULMONOLOGIYA; Том 29, № 2 (2019); 184-188 ; Пульмонология; Том 29, № 2 (2019); 184-188 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2019-29-2

    وصف الملف: application/pdf

    Relation: https://journal.pulmonology.ru/pulm/article/view/1144/908; Yeung J.C., Keshavjee S. Overview of clinical lung transplantation. Cold Spring Harb. Perspect. Med. 2014; 4 (1): a015628. DOI:10.1101/cshperspect.a015628.; Weill D., Dey G.C., Hicks R.A. et al. A positive donor gram stain does not predict outcome following lung transplantation. J. Heart Lung Transplant. 2002; 21 (5): 555–558.; Mattner F., Kola A., Fischer S. et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection. 2008; 36 (3): 207–212. DOI:10.1007/s15010-007-7157-x.; Campos S., Caramori M., Teixeira R. et al. Bacterial and fungal pneumonias after lung transplantation. Transplant. Proc. 2008; 40 (3): 822–824. DOI:10.1016/j.transproceed.2008.02.049.; Bonde P.N., Patel N.D., Borja M.C. et al. Impact of donor lung organisms on post-lung transplant pneumonia. J. Heart Lung Transplant. 2006; 25 (1): 99–105. DOI:10.1016/j.healun.2005.06.026.; Parada M.T., Alba A., Sepulveda C. Early and late infections in lung transplantation patients. Transplant. Proc. 2010; 42 (1): 333–335. DOI:10.1016/j.transproceed.2009.12.002.; Speich R., van der Bij W. Epidemiology and management of infections after lung transplantation. Clin. Infect. Dis. 2001; 33 (Suppl. 1): S58–65. DOI:10.1086/320906.; Dobbin C., Maley M., Harkness J. et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J. Hosp. Infect. 2004; 56 (4): 277–282. DOI:10.1016/j.jhin.2004.01.003.; Hadjiliadis D., Steele M.P., Chaparro C. et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J. Heart Lung Transplant. 2007; 26 (8): 834–838. DOI:10.1016/j.healun.2007.05.018.; Fischer S.A., Avery R.K. Screening of donor and recipient prior to solid organ transplantation. Am. J. Transplant. 2009; 9 (Suppl. 4): S7–18. DOI:10.1111/j.1600-6143.2009.02888.x.; Singh N., Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J. Heart Lung Transplant. 2003; 22 (3): 258–266.; Sims K.D., Blumberg E.A. Common infections in the lung transplant recipient. Clin. Chest Med. 2011; 32 (2): 327–341. DOI:10.1016/j.ccm.2011.02.010.; Avery R.K. Infections after lung transplantation. Semin. Respir. Crit Care Med. 2006; 27 (5): 544–551. DOI:10.1055/s-2006-954612.; Avery R.K. Antifungal prophylaxis in lung transplantation. Semin. Respir. Crit Care Med. 2011; 32 (6): 717–726. DOI:10.1055/s-0031-1295719.; https://journal.pulmonology.ru/pulm/article/view/1144

  16. 16
  17. 17